close

Lessons

  1. Lesson 1: Biotechnology as the manipulation of life: the recombinant DNA debate of the 1970s

    Read More

  2. Lesson 2: Biotechnology as big business: patenting life from Chakrabarty to Myriad

    Read More

  3. Lesson 3: Biotechnology as a new eugenics: genetic testing and reproductive technologies

    Read More

  4. About the Author

    Read More

Introduction

Nadine Weidman has a PhD in History and Philosophy of Science and Technology from Cornell University. She is currently a lecturer in the Department of History of Science at Harvard University. She is the author of Constructing Scientific Psychology: Karl Lashley’s Mind-Brain Debates (Cambridge, 1999), and co–author of Science, Race, and Racism: Social Impact and Interaction (ABC–Clio, 2004). She is currently at work on a book to be entitled “The Killer Instinct: Human Nature as Popular Science in Cold War America,” which examines the debates over a possible human instinct for aggression that engaged scientists and erupted into the popular media in the 1960s and 70s. Her publications stemming from this project include “Popularizing the Ancestry of Man: Robert Ardrey and the Killer Instinct” (Isis, June 2011); and “An Anthropologist on TV: Ashley Montagu and the Biological Basis of Human Nature” in Cold War Social Science (Palgrave, 2012).

Read More

Nearly every day in the news, advances in biotechnology make headlines. Patients desperate for cures seek remedies using stem cells harvested from their own bodies—and fuel a network of international clinics offering experimental treatments. Genetic testing companies like 23andMe promise (for a fee) to tell their customers something about their disease susceptibilities as well as what part of the world their ancestors came from—and adoptees use their services to identify and locate blood relatives. Whole Foods plans by 2018 to become the first supermarket chain in the United States to label products that contain GMOs—genetically modified organisms—while state legislatures ponder legal requirements for such labeling. This higher education class resource seeks to give students the analytical tools they need to understand such news stories by acquainting them with the history of and ethical issues raised by recent biotechnology. We define biotechnology as the manipulation and alteration of an organism’s genetic makeup for the purpose of removing or enhancing certain traits. What used to be possible only through the breeding of plants or animals—by a slow, imprecise process that took generations—now can be accomplished rapidly and precisely by acting directly on the DNA itself, the hereditary material that composes the genes.

Recombinant DNA—the process by which a gene from one organism is spliced into another—was first successfully achieved in 1973, and the first lesson begins with the debate that this technique engendered at the time. The second lesson then considers the industry that grew up around the applications of the technique in agriculture and medicine, and focuses on one specific aspect of the industry—human gene patenting—which allows biotechnology companies to assert proprietary interests in a section of the human genome. Finally, the third lesson turns to the assisted reproductive technologies that use genetic manipulation. Now a matter of choosing the embryos or gametes that will become our children—and perhaps one day enabling us to actually alter their genetic makeup—“reprogenetics” offers us the tantalizing possibility of directly shaping the next generation.

This class resource is interdisciplinary in combining historical case studies with ethical debates. Each of three lessons traces a particular aspect of biotechnology back in time and explores the contexts in which it unfolded, using documents, images, and film footage to recreate the mood and setting of past events. Each lesson then turns to ethics by examining the values of the stakeholders in the debate over that particular biotechnology, then culminates in an ethical debate in which students could be asked to portray the stances of different stakeholders. Ethical debate happens (and is necessary) when difficult choices face us, when there are no clear–cut answers, and when differing but equally important values, cherished by different groups of people, come into conflict. Biotechnology raises a host of ethical questions, none of which has a simple yes–or–no answer. Most often, ethical debate is about deciding where to draw a line; it's about reasoning out to what extent a practice should be pursued or a path taken. Ethics means justifying one’s stance in a way that goes beyond self–interest and impartially considers the greater good. Students usually find that participating in such debates broadens their perspectives and makes them re–think what they believe is right. Playing a role (rather than having to “be themselves”) gives them the freedom to explore and express a range of views.

Engineering the Genes: Ethical Dilemmas in Modern Biotechnology is an adaptation of the university class resource, under the same name, in the archived From DNA to Beer: Harnessing Medicine in Nature and Industry website from 2013.